|
1
|
Olivares-Banuelos TN, Chí-Castañeda D and
Ortega A: Glutamate transporters: Gene expression regulation and
signaling properties. Neuropharmacology. 161(107550)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Amantea D and Bagetta G: Excitatory and
inhibitory amino acid neurotransmitters in stroke: From
neurotoxicity to ischemic tolerance. Curr Opin Pharmacol.
35:111–119. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
You J, Feng L, Xin M, Ma D and Feng J:
Cerebral ischemic postconditioning plays a neuroprotective role
through regulation of central and peripheral glutamate. Biomed Res
Int. 2018(6316059)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kumari S, Mehta SL, Milledge GZ, Huang X,
Li H and Li PA: Ubisol-Q10 prevents glutamate-induced cell death by
blocking mitochondrial fragmentation and permeability transition
pore opening. Int J Biol Sci. 12:688–700. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kumari S, Mehta SL and Li PA: Glutamate
induces mitochondrial dynamic imbalance and autophagy activation:
Preventive effects of selenium. PLoS One. 7(e39382)2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jing L, Kumari S, Mendelev N and Li PA:
Coenzyme Q10 ameliorates ultraviolet B irradiation induced cell
death through inhibition of mitochondrial intrinsic cell death
pathway. Int J Mol Sci. 12:8302–8315. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li H, Chen G, Ma W and Li PA:
Water-soluble coenzyme Q10 inhibits nuclear translocation of
apoptosis inducing factor and cell death caused by mitochondrial
complex I inhibition. Int J Mol Sci. 15:13388–13340.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jing L, He MT, Chang Y, Mehta SL, He QP,
Zhang JZ and Li PA: Coenzyme Q10 protects astrocytes from
ROS-induced damage through inhibition of mitochondrial-mediated
cell death pathways. Int J Biol Sci. 11:59–66. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li HN, Zimmerman M, Milledge GZ, Hou XL,
Cheng J, Wang ZH and Li PA: Water soluble coenzyme Q10 reduced
rotenone-induced mitochondrial fission. Neurochem Res.
42:1096–1103. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Niyazov DM, Kahler SG and Frye RE: Primary
mitochondrial disease and secondary mitochondrial dysfunction:
Importance of distinction for diagnosis and treatment. Mol
Syndromol. 7:122–137. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Failla ML, Chitchumroonchokchai C and Aoki
F: Increased bioavailability of ubiquinol compared to that of
ubiquinone is due to more efficient micellarization during
digestion and greater GSH-dependent uptake and basolateral
secretion by Caco-2 cells. J Agric Food Chem. 62:7174–7182.
2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kalen A, Appelkvist EL and Dallner G:
Age-related changes in the lipid compositions of rat and human
tissues. Lipids. 24:579–584. 1989.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mortenson SA, Rosenfeldt F, Kumar A,
Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G and
Littarru GP: Q-SYMBIO study investigators: The effect of coenzyme
Q10 on morbidity and mortality in chronic heart failure: Results
from Q-SYMBIO: A randomized double-blind trial. JACC Heart Fail.
2:641–649. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Folkers K and Simonsen R: Two successful
double-blind trials with coenzyme Q10 (vitamin Q10) on muscular
dystrophies and neurogenic atrophies. Biochim Biophys Acta.
1271:281–286. 1995.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fallah M, Askari G, Soleimani A, Feizi A
and Asemi Z: Clinical trial of the effects of coenzyme Q10
supplementation on biomarkers of inflammation and oxidative stress
in diabetic hemodialysis patients. Int J Prev Med.
10(12)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sanoobar M, Dehghan P, Khalili M, Azimi A
and Seifar F: Coenzyme Q10 as a treatment for fatigue and
depression in multiple sclerosis patients: A double blind
randomized clinical trial. Nutr Neurosci. 19:138–143.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Valero T: Mitochondrial biogenesis:
Pharmacological approaches. Curr Pharm Des. 20:5507–5509.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Uittenbogaard M and Chiaramello A:
Mitochondrial biogenesis: A therapeutic target for
neurodevelopmental disorders and neurodegenerative diseases. Curr
Pharm Des. 20:5574–5593. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Procaccio V, Bris C, Chao de la Barca JM,
Oca F, Chevrollier A, Amati-Bonneau P, Bonneau D and Reynier P:
Perspectives of drug-based neuroprotection targeting mitochondria.
Rev Neurol (Paris). 170:390–400. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li PA, Hou X and Hao S: Mitochondrial
biogenesis in neurodegeneration. J Neurosci Res. 95:2025–2029.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zimmerman MA, Biggers CD and Li PA:
Rapamycin treatment increases hippocampal cell viability in an
mTOR-independent manner during exposure to hypoxia mimetic, cobalt
chloride. BMC Neurosci. 19(82)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Guzman C, Bagga M, Kaur A, Westermarck J
and Abankwa D: ColonyArea: an ImageJ plugin to automatically
quantify colony formation in clonogenic assays. PLoS ONE.
9(e92444)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Andrews NC and Faller DV: A rapid
micro-preparation technique for extraction of DNA-binding proteins
from limiting numbers of mammalian cells. Nucleic Acids Res.
19(2499)1991.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mehta SL, Kumari S, Mendelev N and Li PA:
Selenium preserves mitochondrial function, stimulates mitochondrial
biogenesis, and reduces infarct volume after focal cerebral
ischemia. BMC Neurosci. 13(79)2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ma YM, Ibeanu G, Wang LY, Zhang JZ, Chang
C, Dong JD, Li PA and Jing L: Selenium suppresses glutamate-induced
cell death and prevents mitochondrial morphological dynamic
alterations in hippocampal HT22 neuronal cells. BMC Neurosci.
18(15)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang X, Li H and Ding S: The effects of
NAD+ on apoptotic neuronal death and mitochondrial biogenesis and
function after glutamate excitotoxicity. Int J Mol Sci.
15:20449–20468. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dinkova-Kostova AT and Abramov AY: The
emerging role of Nrf2 in mitochondrial function. Free Radic Biol
Med. 88:179–188. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hayashi G, Jasoliya M, Sahdeo S, Saccà F,
Pane C, Filla A, Marsili A, Puorro G, Lanzillo R, Brescia Morra V
and Cortopassi G: Dimethyl fumarate mediates Nrf2-dependent
mitochondrial biogenesis in mice and humans. Hum Mol Genet.
26:2864–2873. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bernard K, Logsdon NJ, Miguel V, Benavides
GA, Zhang J, Carter AB, Darley-Usmar VM and Thannickal VJ: NADPH
oxidase 4 (Nox4) suppresses mitochondrial biogenesis and
bioenergetics in lung fibroblasts via a nuclear factor
erythroid-derived 2-like 2 (Nrf2)-dependent pathway. J Biol Chem.
292:3029–3038. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chaturvedi RK and Beal MF: Mitochondrial
diseases of the brain. Free Radic Biol Med. 63:1–29.
2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Khatua TN, Dinda AK, Putcha UK and
Banerjee SK: Diallyl disulfide ameliorates isoproterenol induced
cardiac hypertrophy acting mitochondrial biogenesis via
eNOS-Nrf2-Tfam pathway in rats. Biochem Biophys Rep. 5:77–88.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kang I, Chu CT and Kaufman BA: The
mitochondrial transcription factor TFAM in neurodegeneration:
Emerging evidence and mechanisms. FEBS Lett. 592:793–811.
2018.PubMed/NCBI View Article : Google Scholar
|
